Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass (2019)
- Authors:
- USP affiliated authors: TORRINHAS, RAQUEL SUSANA MATOS DE MIRANDA - FM ; SAKAI, PAULO - FM ; SANTO, MARCO AURELIO - FM ; GIANNELLA, MARIA LUCIA CARDILLO CORREA - FM ; WAITZBERG, DAN LINETZKY - FM
- Unidade: FM
- DOI: 10.1016/j.clnu.2018.05.011
- Subjects: DERIVAÇÃO GÁSTRICA; ÁCIDOS GRAXOS OMEGA 3; EXPRESSÃO GÊNICA; SISTEMA GASTROINTESTINAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Clinical nutrition
- ISSN: 0261-5614
- Volume/Número/Paginação/Ano: v. 38, n. 3, p. 1280-1288, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
GARLA, Priscila et al. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass. Clinical nutrition, v. 38, n. 3, p. 1280-1288, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.clnu.2018.05.011. Acesso em: 30 abr. 2024. -
APA
Garla, P., Sala, P., Torrinhas, R. S. M., Machado, N. M., Fonseca, D. C., Silva, M. M. da, et al. (2019). Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass. Clinical nutrition, 38( 3), 1280-1288. doi:10.1016/j.clnu.2018.05.011 -
NLM
Garla P, Sala P, Torrinhas RSM, Machado NM, Fonseca DC, Silva MM da, Ravacci GR, Sakai P, Santo MA, Giannella MLCC, Waitzberg DL. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass [Internet]. Clinical nutrition. 2019 ; 38( 3): 1280-1288.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1016/j.clnu.2018.05.011 -
Vancouver
Garla P, Sala P, Torrinhas RSM, Machado NM, Fonseca DC, Silva MM da, Ravacci GR, Sakai P, Santo MA, Giannella MLCC, Waitzberg DL. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass [Internet]. Clinical nutrition. 2019 ; 38( 3): 1280-1288.[citado 2024 abr. 30 ] Available from: https://doi.org/10.1016/j.clnu.2018.05.011 - Genetic reprogramming of rHemnant duodenum may contribute to type 2 diabetes improvement after Roux-en-Y gastric bypass
- Gastrointestinal Transcriptomic Response of Metabolic Vitamin B12 Pathways in Roux-en-Y Gastric Bypass
- Intestinal expression of toll-like receptor gene changes early after gastric bypass surgery and association with type 2 diabetes remission
- Type 2 diabetes metabolic improvement after roux-en-Y gastric bypass may include a compensatory mechanism that balances fatty acid beta and omega oxidation
- Cholecystectomy - a potential selection bias in studies assessing the metabolic effects of bariatric surgeries
- The SURMetaGIT study: design and rationale for a prospective pan-omics examination of the gastrointestinal response to Roux-en-Y gastric bypass surgery
- Sarcopenia in liver cirrhosis: the role of computed tomography scan in the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry [Carta]
- High-Fiber Orange Juice as a Nutrition Supplement in Women: A Randomized, Double-Blind, Placebo-Controlled Study of Tolerance and Effectiveness
- Infusion time for fish oil-containing parenteral emulsions in surgery: A study on omega-3 fatty acid dynamics in rats
- Fecal bile acid profile after Roux-en-Y gastric bypass and its association with the remission of type 2 diabetes in obese women: A preliminary study
Informações sobre o DOI: 10.1016/j.clnu.2018.05.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
